Evogene Ltd.Find Ratings Reports
EVOGENE LTD's gross profit margin for the fourth quarter of its fiscal year 2021 has significantly increased when compared to the same period a year ago. Even though sales decreased, the net income has increased. EVOGENE LTD is extremely liquid. Currently, the Quick Ratio is 8.01 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has increased from the same period last year.
During the same period, stockholders' equity ("net worth") has increased by 17.34% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY21||Q4 FY20|
|Net Sales ($mil)||0.31||0.35|
|Net Income ($mil)||-7.37||-8.12|
|Balance Sheet||Q4 FY21||Q4 FY20|
|Cash & Equiv. ($mil)||53.94||48.28|
|Total Assets ($mil)||76.3||71.92|
|Total Debt ($mil)||2.67||2.44|
|Profitability||Q4 FY21||Q4 FY20|
|Gross Profit Margin||14.15||1.42|
|Return on Assets||-36.42||-32.5|
|Return on Equity||-51.44||-50.76|
|Debt||Q4 FY21||Q4 FY20|
|Share Data||Q4 FY21||Q4 FY20|
|Shares outstanding (mil)||41.17||35.6|
|Div / share||0.0||0.0|
|Book value / share||1.31||1.29|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||295645.0||324720.0|
SELL. The current P/E ratio is negative, which has no meaningful value in the assessment of premium or discount valuation, it simply displays that the company has negative earnings. For additional comparison, its price-to-book ratio of 0.70 indicates a significant discount versus the S&P 500 average of 3.78 and a significant discount versus the subsector average of 14.34. The price-to-sales ratio is well above both the S&P 500 average and the subsector average, indicating a premium. The valuation analysis reveals that, EVOGENE LTD seems to be trading at a premium to investment alternatives.
|EVGN NM||Peers 59.54||EVGN NM||Peers 19.52|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
EVGN's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
EVGN's P/CF is negative making the measure meaningless.
|EVGN NM||Peers 17.22||EVGN NA||Peers 0.91|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
EVGN's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|EVGN 0.70||Peers 14.34||EVGN 15.86||Peers 126.03|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
EVGN is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, EVGN is expected to significantly trail its peers on the basis of its earnings growth rate.
|EVGN 40.73||Peers 16.59||EVGN -10.58||Peers 307.28|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
EVGN is trading at a significant premium to its subsector.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
EVGN significantly trails its peers on the basis of sales growth.